| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/02/1996 | WO1996012499A1 Amidino and guanidino substituted inhibitors of trypsin-like enzymes |
| 05/02/1996 | CA2203364A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 05/02/1996 | CA2203363A1 Binding agents to cd23 |
| 05/02/1996 | CA2203262A1 Nucleoside derivatives and process for preparing thereof |
| 05/01/1996 | EP0709386A1 Fused benzazepine derivative and pharmaceutical composition containing the same |
| 05/01/1996 | EP0709381A1 Heterocyclic compounds and their preparation and use |
| 05/01/1996 | EP0709375A2 Therapeutic heterocycles |
| 05/01/1996 | EP0708771A1 Benzyloxyquinuclidines as substance p antagonists |
| 05/01/1996 | EP0708768A1 Tri-substituted imidazoles having multiple therapeutic properties |
| 05/01/1996 | EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 05/01/1996 | EP0708640A1 Pharmaceutical preparations with an active principle containing modified amidin groups |
| 05/01/1996 | CN1121714A Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives |
| 04/30/1996 | US5512588 Antiulcer agents |
| 04/30/1996 | US5512579 Aminobenzoic acid derivatives |
| 04/30/1996 | US5512576 2-substituted 1,2,5,-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |
| 04/30/1996 | US5512570 Treatment of emesis with morpholine tachykinin receptor antagonists |
| 04/30/1996 | US5512563 Tricyclic benzazepine vasopressin antagonists |
| 04/30/1996 | CA1338302C Therapeutic octapeptide somatostatin analogs |
| 04/30/1996 | CA1338287C Hetrazepines and processes for preparing them |
| 04/25/1996 | WO1996011953A1 N-terminally chemically modified protein compositions and methods |
| 04/25/1996 | WO1996011950A1 Method of treating diabetes mellitus using kgf |
| 04/25/1996 | WO1996011949A2 Analogs of keratinocyte growth factor |
| 04/25/1996 | WO1996011940A1 Acyl amino acetamide derivatives with agonist activity for cck-a receptors |
| 04/25/1996 | WO1996011685A2 Use of indole derivatives for the treatment of various diseases |
| 04/25/1996 | WO1996011681A1 Preventive and remedy for diarrhea |
| 04/25/1996 | CA2472085A1 N-terminally chemically modified protein compositions and methods |
| 04/25/1996 | CA2202389A1 Agent for preventing and treating diarrhea |
| 04/25/1996 | CA2161176A1 Heterocyclic compounds and their preparation and use |
| 04/24/1996 | EP0708101A1 Novel piperidine derivatives, useful as neurokinin receptor antagonists |
| 04/24/1996 | EP0707855A2 Combination therapy for chronic hepatitis C infection |
| 04/24/1996 | EP0707854A2 Compositions for the treatment of gastronitestinal disorders containing bismuth and an antimicrobial |
| 04/24/1996 | EP0707849A1 Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors |
| 04/24/1996 | EP0707638A1 Regulatable nucleic acid therapeutic and methods of use thereof |
| 04/24/1996 | EP0707580A1 Magnesium omeprazole |
| 04/24/1996 | EP0707571A1 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives as 5ht1a ligands |
| 04/24/1996 | EP0707485A1 Anti-cholesterolemic egg, vaccine and method for production, and use |
| 04/24/1996 | EP0707484A1 H 2? antagonist-alginate-antacid combinations |
| 04/24/1996 | EP0707481A1 L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents |
| 04/24/1996 | EP0450097B1 Benzoheterocyclic compounds |
| 04/24/1996 | CN1121348A Indole derivatives as 5-H1-like agonists for use in migraine |
| 04/24/1996 | CN1121311A Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
| 04/24/1996 | CN1120941A Stomachic tablet and its production method |
| 04/23/1996 | USRE35218 For gastrointestinal disorders |
| 04/23/1996 | US5510384 Topical application as wound healing agent |
| 04/23/1996 | US5510382 Administering prostaglandin e derivatives |
| 04/23/1996 | US5510353 Treating irritable bowel syndrome, gastroesophageal reflux disease, constipation, migraine headaches |
| 04/23/1996 | US5510327 Containing tumor cytotoxic factor, basic amino acid or salt thereof, organic or inorganic salt |
| 04/18/1996 | WO1996011258A1 Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same |
| 04/18/1996 | WO1996011209A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/18/1996 | WO1996011195A1 Indole derivatives as 5ht1-like agonists |
| 04/18/1996 | CA2202027A1 Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same |
| 04/18/1996 | CA2201639A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/17/1996 | EP0707006A1 Aroyl-piperidine derivatives |
| 04/17/1996 | EP0707004A1 1-Arylalcenyl 4-arylmethylpiperazinderivatives, process for their preparation and pharmaceutical composition containing them |
| 04/17/1996 | EP0706528A1 Fucosylated glycosides as inhibitors of bacterial adherence |
| 04/17/1996 | EP0706400A1 Therapeutic formulation and method |
| 04/17/1996 | EP0706394A1 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient |
| 04/17/1996 | EP0706386A1 Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders |
| 04/17/1996 | EP0706378A1 New pharmaceutical formulation |
| 04/17/1996 | CN1120845A 1,5 benzodiazepine derivatives having CCK and/or gastrin antagonistic activity |
| 04/17/1996 | CN1120443A "Danshenye" Chinese medicinal liquid for treatment of cholecystitis |
| 04/17/1996 | CN1120433A "Weiling" gastritis oral liquid and its prepn. method |
| 04/16/1996 | US5508385 Protease inhibitor; antiulcer agents, antiinflammatory agents; treating pancreatitis |
| 04/16/1996 | US5508310 Immunopotentiatory agents and physiologically acceptable salts thereof |
| 04/16/1996 | US5508288 Indole derivatives as 5HT1C antagonists |
| 04/16/1996 | US5508284 Treating 5-hydroxytryptamine modulation |
| 04/16/1996 | US5508265 Administering to prevent accumulation of excess, extracellular free actin and to inhibit secondary tissue injury |
| 04/16/1996 | US5508262 Interleukin-1 receptor antagonist decreases severity of acute pancreatitis |
| 04/11/1996 | WO1996010639A2 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION AND GASTRIC CARCINOMA |
| 04/11/1996 | WO1996010571A1 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO[1,2-a]PYRAZINE DERIVATIVES |
| 04/11/1996 | WO1996005838A3 Combined preparation for the therapy of immune diseases |
| 04/11/1996 | CA2201353A1 The taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| 04/11/1996 | CA2160214A1 1-arylalkenyl 4-arylmethyl piperazine structure-like derivatives; process for preparing them and pharmaceutical compositions containing them |
| 04/10/1996 | EP0705832A1 Serotonergic modulators |
| 04/10/1996 | EP0705831A2 Cycloalkano-indole- and -azaindole derivatives |
| 04/10/1996 | EP0705827A1 Interleukin-1 inhibiting manumycin derivatives and streptomyces strains for their production |
| 04/10/1996 | EP0448697B1 Vitamin a analogues and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/10/1996 | CN1120351A An alpha-galactosidase enzyme |
| 04/10/1996 | CN1120339A New prednisolone derivates |
| 04/10/1996 | CN1120038A Substituted ester of piperidine-1-alcohol, preparation and pharmaceutical use of same |
| 04/10/1996 | CN1119950A Traditional Chinese medicine "Zhenhuang" powder and its production method |
| 04/09/1996 | US5506264 Antiulcer, antiinflammatory agents; reacting tranexamic acid with zinc compound and alkali agent |
| 04/09/1996 | US5506242 Arylsufonamido-substituted hydroxamic acids |
| 04/09/1996 | US5506133 Polypeptide |
| 04/04/1996 | WO1996010027A1 N-substituted piperidinyl bicyclic benzoate derivatives |
| 04/04/1996 | WO1996009835A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | WO1996004933A3 Cck antibodies used to improve feed efficiency |
| 04/04/1996 | CA2197657A1 Novel mitogen activated protein kinase, frk |
| 04/03/1996 | EP0704214A1 Process for obtaining pure nizatidine |
| 04/03/1996 | EP0704212A2 Method of minimizing hepatic reperfusion injury |
| 04/03/1996 | EP0704202A1 Anti-cariogenic agent |
| 04/03/1996 | EP0704057A1 Novel clinical marker and therapeutic agent in kidney stone disease and methods of use |
| 04/03/1996 | EP0703914A1 8-amino-7-chloro-1,4-benzodioxan-5-carboxylic acid, -1-butyl-4-piperidinyl ester as a 5-ht4-receptor antagonist |
| 04/03/1996 | EP0703897A1 Lipoxin compounds |
| 04/03/1996 | CN1119863A Imidazopyridines and their use in treating gastrointestinal diseases |
| 04/03/1996 | CN1119643A Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their ... |
| 04/03/1996 | CN1119541A Gargle made of sarcandra glabra |
| 04/02/1996 | US5503848 Topical dose of sterile, slow-release, lyophilized non-crosslinked hyaluronic acid ester; wound healing agents, ears |
| 04/02/1996 | US5503845 Produced by intensive moistening of active ingredient with more than 30 weight per cent water in a granulator with maximum energy input |
| 03/31/1996 | CA2159257A1 Interleukin-1 production inhibiting compound |